News

Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop ...
NSC51349 selectively inhibits cutaneous HPV replication by targeting viral E2 activity, potentially paving the way for first ...
Fujifilm’s Life Sciences Group is renaming two of its companies, in a rebranding intended to position parent company Fujifilm as a strategic partner.
A new machine learning approach identifies cellular senescence at single-cell resolution across varying cell types and tissue ...
Axplora reports that it has invested €35 million ($40.2 million) to expand its Farmabios site in Gropello Cairoli, Italy. This follows a previous €45 million ($52.7 million) investment which brings ...
Single-cell RNA-seq (scRNA-seq) has spent the past decade maturing into a foundational technology. Over that time, the ...
Patients on baseline steroids had lower ORR, and markedly shorter PFS survival and OS compared with those not receiving ...
Two of Cytiva’s top executives offer updates on the company's $1.6 billion in expansion projects worldwide, all to meet growing market demand for its services from developers and manufacturers of ...
If a gene is evolutionarily conserved, that shows it must be doing something important. Otherwise, nature would let it go.
While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.
Bacteria and their phage, “are full of mysteries and also lots of really powerful mechanisms that we can study and potentially harness.” ...
Recent developments in protein-protein interactions (PPI) give hope for patients with advanced or untreatable diseases.